Mary EllenMartinMD

Hematologic Oncology

Physician

Dr. Martin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Civic Center Blvd, South Pavilion, 12-152
Philadelphia, PA 19104
Phone+1 215-349-8940

Fax+1 215-615-5887

University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1996 - 1999
State University of New York Downstate Medical Center College of MedicineClass of 1996

PubMed

815 citations
MLL targets SET domain methyltransferase activity to Hox gene promoters.
Thomas A. Milne, Scott D. Briggs, Hugh W. Brock, Mary Ellen Martin, Denise Gibbs
Molecular Cell. 2002-11-01
45 citations
Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia.
Andrew H Matthews, Alexander E Perl, Selina M Luger, Alison W Loren, Saar I Gill
Blood Advances. 2022-07-12
32 citations
Tocilizumab for the treatment of severe steroid-refractory acute graft-versus-host disease of the lower gastrointestinal tract.
Alex Ganetsky, Noelle V. Frey, Elizabeth O. Hexner, Alison W. Loren, Saar Gill
Bone Marrow Transplantation. 2019-02-01

Abstracts/Posters

Fried Frailty Phenotype Predicts Mortality for Newly Diagnosed Older Patients with Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Mary Ellen Martin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Outcomes of Allogeneic Stem Cell Transplantation for AML and MDS Based on Pre-Transplant MRD Status By Next-Generation Sequencing
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018